Page last updated: 2024-11-05

n-hydroxy-n-(2-fluorenyl)benzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-hydroxy-N-(2-fluorenyl)benzamide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19347
CHEMBL ID311673
MeSH IDM0207154

Synonyms (16)

Synonym
CHEMBL311673
n-hydroxy-2-benzoylaminofluorene
ccris 2719
n-hydroxy-n-(2-fluorenyl)benzamide
n-hydroxy-n-2-fluorenylbenzamide
brn 2758983
n-fluoren-2-ylbenzohydroxamic acid
benzamide, n-9h-fluoren-2-yl-n-hydroxy-
n-benzoyloxy-acetylaminofluorene
benzohydroxamic acid, n-fluoren-2-yl-
n-(9h-fluoren-2-yl)-n-hydroxybenzamide
qs2a8uw3hc ,
unii-qs2a8uw3hc
3671-71-4
DTXSID20190174
n-9h-fluoren-2-yl-n-hydroxybenzamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID167947Carcinogenic activity on ear duct after intraperitoneal administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID167936Carcinogenic activity on breast after intraperitoneal administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID168108Compound was tested for carcinogenic activity on other sites after intraperitoneal administration of the compound; + denotes carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID167925Carcinogenic activity on all sites after intraperitoneal administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID31274Methylthio adduct formation rate expressed as nanomoles of methylthio adduct formed per mg of protein per 30 min1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Arylhydroxamic acid bioactivation via acyl group transfer. Structural requirements for transacylating and electrophile-generating activity of N-(2-fluorenyl)hydroxamic acids and related compounds.
AID31275AHAT catalyzed transacylation was determined; Rate expressed as nanomoles of AAB acylated per mg of protein per 5 min1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Arylhydroxamic acid bioactivation via acyl group transfer. Structural requirements for transacylating and electrophile-generating activity of N-(2-fluorenyl)hydroxamic acids and related compounds.
AID168083Carcinogenic activity on liver after intraperitoneal administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]